On August 14, 2026, Kahn Swick & Foti, LLC filed a verified stockholder derivative complaint in the United States District Court for the Southern District of New York on behalf of nominal defendant Medical Properties Trust, Inc. (“MPT”), a self-advised real estate investment trust that acquires and leases hospitals and other healthcare facilities, against three of MPT’s most senior officers and the nine members of its current board of directors. Plaintiff alleges that MPT’s chief executive officer, chief financial officer, and chief accounting officer breached their fiduciary duties by concealing a hostile regulatory order — a July 20, 2023 order of the California Department of Managed Health Care postponing the effectiveness of, and prohibiting implementation of, a restructuring transaction with MPT’s third-largest tenant — and by causing MPT to recognize approximately $68 million of blocked, contingent “equity” as current revenue, which allegedly inflated the non-GAAP metric used to set their own incentive compensation. Plaintiff further alleges that MPT’s board acted in bad faith by wrongfully refusing his November 4, 2025 litigation demand, and asserts claims for abuse of control, gross mismanagement, waste of corporate assets, unjust enrichment, and contribution under Sections 10(b) and 21D of the Securities Exchange Act of 1934. Plaintiff seeks restitution and compensatory damages for MPT, disgorgement of improperly obtained profits and other monetary gains by the individual defendants, and corporate governance reforms.